Skip to main content

Incyte to acquire North Carolina drug developer in deal valued at up to $1.36 billion

The deal involving an experimental skin disorder drug includes an upfront payment of $70 million.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.